首页> 外文期刊>International journal of oncology >Radiation-inducible silencing of uPA and uPAR in vitro and in vivo in meningioma
【24h】

Radiation-inducible silencing of uPA and uPAR in vitro and in vivo in meningioma

机译:脑膜瘤体内外uPA和uPAR的辐射诱导沉默

获取原文
获取外文期刊封面目录资料

摘要

Stereospecific radiation treatment offers a distinct opportunity for temporal and spatial regulation of gene expression at tumor sites by means of inducible promoters. To this end, a plasmid, pCArG-U2, was constructed by incorporating nine CArG elements (in tandem) of EGR1 gene upstream to uPA and uPAR siRNA oligonucleotides in a pCi-neo vector. Radiation-induced siRNA expression was detected in a meningioma cell line (IOMM-Lee). Immunoblotting and RT-PCR analyses confirmed downregulation of uPA and uPAR. A similar effect was observed in transfected cells followed by H2O2 treatment. Moreover, pre-treatment of transfected cells with N-acetyl L-cysteine blocked the silencing of uPA and uPAR, which further confirmed the oxidative damage-mediated downregulation. Cell proliferation assays and Western blot analysis for apoptotic molecules confirmed cell death in a radiation-inducible fashion. Migration and matrigel invasion assays also revealed a marked decrease in migration and invasion. Immunocytochemistry showed a marked decrease in uPA and uPAR levels in transfected and irradiated cells. H&E staining revealed a decrease in the pre-established tumor volume among the animals treated with pCArG-U2 and radiation. Immunohistochemistry of the brain sections established with intracranial tumors also revealed a marked decrease in uPA and uPAR in a radiation-inducible fashion. Taken together, our data suggest pCArG-U2 as a suitable candidate for radiation-inducible gene therapy.
机译:立体定向放射治疗通过诱导型启动子为肿瘤部位基因表达的时空调节提供了独特的机会。为此,通过在pCi-neo载体中将uPA和uPAR siRNA寡核苷酸上游的EGR1基因的九个CArG元件(串联)整合进pCArG-U2质粒中。在脑膜瘤细胞系(IOMM-Lee)中检测到辐射诱导的siRNA表达。免疫印迹和RT-PCR分析证实了uPA和uPAR的下调。在转染的细胞中进行过氧化氢处理后,观察到了类似的效果。此外,用N-乙酰基L-半胱氨酸预处理转染的细胞可阻断uPA和uPAR的沉默,从而进一步证实了氧化损伤介导的下调。凋亡分子的细胞增殖测定和蛋白质印迹分析证实了辐射诱导方式的细胞死亡。迁移和基质胶侵袭试验也显示出迁移和侵袭的明显减少。免疫细胞化学显示,转染和辐照细胞的uPA和uPAR水平明显降低。 H&E染色显示,在用pCArG-U2和放射线治疗的动物中,预先确定的肿瘤体积减少了。颅内肿瘤建立的大脑切片的免疫组织化学还显示,uPA和uPAR以辐射诱导方式显着降低。综上所述,我们的数据表明pCArG-U2是放射线诱导基因治疗的合适候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号